Article
15 Sep 2026
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
AUTHORS CONTENT
Article
10 Aug 2026
FDA Approves Meitheal Pharmaceuticals’ Insulin Aspart Biosimilar GARZULYS
Article
27 Apr 2026
Eli Lilly To Acquire Kelonia Therapeutics
Article
27 Apr 2026
Sun Pharma To Acquire Organon
Article
01 Apr 2026
Accord, Intas, And Bio-Thera File Four IPRs Against Janssen Golimumab Patents
Article
27 Feb 2026
New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO
Article
18 Dec 2025
European Biosimilar Updates – Six Denosumab Launches And Positive Opinion For Samsung Bioepis's BYOOVIZ
Article
19 Nov 2025
New FDA Guidance Aims To Simplify The Biosimilar Approval Process
Article
13 Nov 2025
Amgen Files BPCIA Complaints Against Dr. Reddy's/Alvotech And Amneal Regarding Denosumab Biosimilars
Article
09 Oct 2025
Biogen Ordered To Pay Genentech $88.3 Million In Past Royalties On Cabilly Patents
Article
08 Oct 2025
Court Denies Amgen Motion To Dismiss In Etanercept Antitrust Case
Article
08 Oct 2025
PTAB Issues Four IPR Written Decisions In Merck And Johns Hopkins Pembrolizumab Dispute
Article
08 Oct 2025
Amgen And Samsung Bioepis Settle Denosumab BPCIA Case
Article
26 Sep 2025
Amgen Fires Back With Counterclaims In Aflibercept BPCIA Litigation
Article
22 Sep 2025
Alvotech Files PGR Against Regeneron High-Dose Aflibercept Patent
Article
04 Sep 2025
European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance
Article
01 Aug 2025
Harrow Enters Agreement To Commercialize Samsung Bioepis's Ophthalmology Biosimilars Following Biogen's Exit
Article
01 Aug 2025
Bio-Thera Announces Acceptance Of BLA For BAT2506 Referencing Johnson & Johnson's SIMPONI® (Golimumab)
Article
30 Jul 2025
Amgen And Accord BioPharma Settle Denosumab BPCIA Case
Article
25 Jun 2025
Teva And Fosun Partner To Develop A Novel Immunotherapy Targeting Melanoma And Other Cancers